BF
Brendan L. Flannery

Elite Scholar

350
Works
13,351
Citations
63
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Brendan L. Flannery

Also known as: B Flannery, B. Flannery, Brendan Flannery, Brendan L Flannery, Brendan L. Flannery

350

Total Works

13,351

Citations

63

H-Index

179

i10-Index

Citation & Works Trend by Year
30 years active
Top Research Topics
Influenza Virus Research Studies (197) Respiratory viral infections research (182) Vaccine Coverage and Hesitancy (169) Bacterial Infections and Vaccines (59) Pneumonia and Respiratory Infections (46)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25 The Journal of Infectious Diseases 0
2026 Differences in SARS-CoV-2 rapid diagnostic testing usage by COVID-19 vaccination status can bias vaccine effectiveness estimates against symptomatic SARS-CoV-2 infection from a test-negative design International Journal of Epidemiology 0
2026 Comparative immunogenicity and relative vaccine efficacy of recombinant and cell culture-based influenza vaccines: Results from a randomized trial of adults in the United States, 2024-2025 medRxiv 0
2026 Implications of patient self-testing on test-negative design for influenza, COVID-19 and RSV vaccine effectiveness International Journal of Epidemiology 0
2026 Influenza Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department or Urgent Care Encounters Among Children and Adults—VISION, United States, 2024–2025 Season Open Forum Infectious Diseases 0
2026 Comparison of Influenza Vaccine Effectiveness Estimates Using Test-Negative Prospective Enrollment and Electronic Health Record Data, United States, 2024–2025 medRxiv 0
2026 Influenza Antibody Levels Associated With Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu Vaccine Effectiveness Network, November 2018 to May 2019 The Journal of Infectious Diseases 0
2026 Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season Clinical Infectious Diseases 1
2026 Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines npj Vaccines 0
2026 Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016–2025 PEDIATRICS 3
2026 Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025 JAMA Network Open 2
2026 Birth Cohort Effects in Adults Associated With Influenza A(H1N1)pdm09 Vaccine Effectiveness The Journal of Infectious Diseases 0
2026 Influenza Vaccines for Persons Who Are Immunocompromised: A Scoping Review of the Literature Open Forum Infectious Diseases 0
2026 Comparison of influenza hemagglutination inhibition titers from capillary blood versus venipuncture Journal of Clinical Virology 0
2026 Effects of Age and Birth Cohort on Influenza A Virus Subtype-Specific Hospitalization Rates, United States, 2010–2025 The Journal of Infectious Diseases 0

Data source: OpenAlex API